MonoRab™ Anti-Risankizumab Antibody (32A12), mAb, Rabbit产品图
文献支持

MonoRab™ Anti-Risankizumab Ant

ibody (32A12), mAb, Rabbit
收藏
  • 询价
  • GenScript/金斯瑞
  • 中国
  • A02322-40
  • 2026年08月19日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 库存:

      42

    • 供应商:

      广州市左克生物

    • 规格:

      40 μg

    因品牌产品种类较多,未能全部上架,找货询货可直接联系在线客服咨询。“ 在线询价 ” 只能发布文字,图片以及文件是不支持的,建议添加微信/QQ

    产品简介:

    货号:A02322-40

    产品名称:MonoRab™ Anti-Risankizumab Antibody (32A12), mAb, Rabbit

    产品规格:40 μg

    产品介绍文本:

    产品概述HTML:

    产品概述
    Specificity This product is specific for Risankizumab.
    Host Species Rabbit
    Immunogen Risankizumab
    Conjugate Unconjugated
    返回

    产品属性HTML:

    产品属性
    Form Lyophilized
    Storage Buffer Lyophilized with PBS, pH 7.2, containing 0.02% sodium azide.
    Reconstitution Reconstitute the lyophilized antibody with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.
    Storage Instructions The lyophilized product remains stable for 1 year at -20℃ from the date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8℃ or for 12 months at -20℃ or below. Avoid repeated freezing and thawing cycles.
    Purification Protein A affinity column
    Isotype Rabbit IgG, κ
    Clonality Monoclonal
    Clone ID 32A12
    Note GenScript can customize this product per customer's request including product size, buffer components, etc.
    返回

    产品简介HTML:

    应用指导HTML:

    应用指导
    Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
    Application Recommended Usage
    Sandwich ELISA 0.5-2 μg/ml
    ELISA 0.01-1 µg/ml
    Competitive ELISA 1-10 μg/ml
    返回

    技术背景HTML:

    技术背景
    Target Background Risankizumab is a monoclonal antibody designed to target interleukin-23 (IL-23), a key cytokine involved in the inflammatory process of certain autoimmune diseases. By specifically binding to the p19 subunit of IL-23, Risankizumab inhibits its interaction with the IL-23 receptor, thereby reducing inflammation and immune responses. This mechanism makes Risankizumab particularly effective in the treatment of moderate to severe plaque psoriasis. The drug is marketed under the brand name Skyrizi and has shown superior efficacy compared to other biologics in its class. It is also being studied for potential use in other inflammatory conditions, such as Crohn's disease.
    Synonyms Risankizumab; risankizumab-rzaa; Skyrizi; ABBV-066; BI-655066; BI 655066
    返回

    相关文献HTML:

    产品细节图片1

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    官网有文献
    相关实验
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    广州市左克生物科技发展有限公司
    2026年08月19日询价
    ¥1338
    武汉益普生物科技有限公司
    2026年08月30日询价
    ¥1338
    武汉研升生物科技有限公司
    2026年09月03日询价
    ¥969
    深圳欣博盛生物科技有限公司
    2025年07月12日询价
    询价
    上海北诺生物科技有限公司
    2025年07月11日询价
    文献支持
    MonoRab™ Anti-Risankizumab Antibody (32A12), mAb, Rabbit
    询价